EUVIMEDEUVIMED entdecken
Crossref

A microfluidic biomimetic system from the blood-brain barrier to activated microglia towards anti-Mesial Temporal Lobe Epilepsy drug screening

Yunhua Wang, Meng Du, Zhanfei Xie, Huicheng Chen, Ling Lu, Lan Jiang, Lin Wang, Guoxia Zheng

Analytical and Bioanalytical Chemistry · 2026

DOI: 10.1007/s00216-025-06259-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical and Bioanalytical Chemistry, 2026. Verfasst von Yunhua Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, Dalian University, Dalian, 116622, China. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Microglia, Epilepsy, Temporal Lobe, Anticonvulsants. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Interdisciplinary project of Dalian University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of drugs for mesial temporal lobe epilepsy (mTLE) is hampered by the absence of preclinical models that can concurrently evaluate blood-brain barrier (BBB) penetration and target efficacy. To bridge critical gaps in preclinical screening, we developed an integrated microfluidic µBBB-(KA-MG)-mTLE chip that simultaneously models a perfusable human BBB under physiological shear stress (0.03-2.04 dyn/cm2) and a neuroinflammatory mTLE microenvironment with activated microglia. This platform enabled the dual-parameter assessment of drug candidates, quantifying their BBB permeability and anti-inflammatory activity in a single experiment. In a practical screening application, osthole was identified as a promising candidate for its adequate brain exposure and potent efficacy, whereas a high molecular weight grape seed extract showed activity only when bypassing the BBB, demonstrating the platform's critical ability to de-risk candidate selection. Our biomimetic system provides a transformative tool for anti-epileptic drug discovery by integrating pharmacokinetic and pharmacodynamic evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood-Brain BarrierMicrogliaEpilepsy, Temporal LobeAnticonvulsantsBiomimeticsLab-On-A-Chip DevicesHumansDrug Evaluation, Preclinical

Stichwörter der Autor:innen

Anti-mTLEBlood-brain barrierDrug screeningMicrofluidicsPermeability

Substanzen

Anticonvulsants

Autor:innen und Institutionen

  • Medical School, Dalian University, Dalian, 116622, China.
  • Key Laboratory of Biophysics of Liaoning Province, Dalian, 116622, China.
  • Department of Clinical Laboratory, Huaian Hospital of Huaian City, Huaian, 223200, Jiangsu, China.
  • Environmental and Chemical Engineering Institute, Dalian University, Dalian, 116622, China.
  • Department of Obstetrics and Reproductive Medicine, Affiliated Hospital of Yunnan University, Kunming, 650021, Yunnan, China.
  • Key Laboratory of Biophysics of Liaoning Province, Dalian, 116622, China. Wanglin1@dlu.edu.cn.

Förderung

  • Interdisciplinary project of Dalian University

Zitieren

APA

Wang, Y., Du, M., Xie, Z., Chen, H., Lu, L., Jiang, L., Wang, L., & Zheng, G. (2026). A microfluidic biomimetic system from the blood-brain barrier to activated microglia towards anti-Mesial Temporal Lobe Epilepsy drug screening. Analytical and Bioanalytical Chemistry. https://doi.org/10.1007/s00216-025-06259-3

Vancouver

Wang Y, Du M, Xie Z, Chen H, Lu L, Jiang L, et al. A microfluidic biomimetic system from the blood-brain barrier to activated microglia towards anti-Mesial Temporal Lobe Epilepsy drug screening. Analytical and Bioanalytical Chemistry. 2026. doi:10.1007/s00216-025-06259-3

BibTeX
@article{Wang2026,
  author = {Wang, Yunhua and Du, Meng and Xie, Zhanfei and Chen, Huicheng and Lu, Ling and Jiang, Lan and Wang, Lin and Zheng, Guoxia},
  title = {A microfluidic biomimetic system from the blood-brain barrier to activated microglia towards anti-Mesial Temporal Lobe Epilepsy drug screening},
  journal = {Analytical and Bioanalytical Chemistry},
  year = {2026},
  doi = {10.1007/s00216-025-06259-3}
}
Kostenlos starten →